Stay updated on Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A new site revision label (v3.5.4) has been added, replacing the previous revision (v3.5.3). This indicates a platform update rather than a modification to the study details.
    Difference
    0.1%
    Check dated 2026-05-15T14:26:21.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The page now shows an updated site revision identifier (moving from v3.5.2 to v3.5.3), indicating a platform/version update without altering the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:39:43.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:55:09.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.3 to v3.5.0.
    Difference
    0.1%
    Check dated 2026-03-19T05:32:49.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-12T00:34:14.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    The page adds Revision: v3.4.2, and removes a government funding lapse notice and the older Revision: v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T14:09:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in CAR T Failure Lymphomas Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in CAR T Failure Lymphomas Clinical Trial page.